Nintedanib and symptoms of fibrotic lung disease: a glimmer of hope for patients living with pulmonary fibrosis. Editorial Article uri icon

Overview

abstract

  • Treatment with nintedanib slows the worsening of dyspnoea and fatigue, stabilises the degree of impact of pulmonary fibrosis, and may actually improve cough https://bit.ly/3S01WbX

publication date

  • February 1, 2024

Research

keywords

  • Idiopathic Pulmonary Fibrosis
  • Lung

Identity

PubMed Central ID

  • PMC11247642

Scopus Document Identifier

  • 85184344854

Digital Object Identifier (DOI)

  • 10.1183/13993003.00067-2024

PubMed ID

  • 38302183

Additional Document Info

volume

  • 63

issue

  • 2